Conroe Willis Medical Research

Conroe, Texas 77304

0 studies enrolling now · 6 studies all time

What they study most

Alzheimer Disease, COVID-19, Diabetes Complications, Diabetes Mellitus, Diabetic Nephropathies, Endocrine System Diseases, Glomerulonephritis, Glomerulosclerosis, Focal Segmental, Kidney Diseases, Nephritis, Nephrosis, Nephrosis, Lipoid

Studies at this site

• A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3) — Running, not enrolling
• EPIC-HR: Study of Oral PF-07321332/Ritonavir Compared With Placebo in Nonhospitalized High Risk Adults With COVID-19 — Completed
• Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR). — Stopped early
• A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection — Completed
• A Study of TRPC5 Channel Inhibitor in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change Disease — Stopped early
• A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness — Completed